Cargando…

Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure

AIMS: Patients with a systemic right ventricle (sRV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA are prone to heart failure and arrhythmias. This study evaluated feasibility, patient adherence, and satisfaction of a smart technology-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nederend, Marieke, Zandstra, Tjitske E, Kiès, Philippine, Jongbloed, Monique R M, Vliegen, Hubert W, Treskes, Roderick W, Schalij, Martin J, Atsma, Douwe E, Egorova, Anastasia D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707956/
https://www.ncbi.nlm.nih.gov/pubmed/36712397
http://dx.doi.org/10.1093/ehjdh/ztab028
_version_ 1784840815681470464
author Nederend, Marieke
Zandstra, Tjitske E
Kiès, Philippine
Jongbloed, Monique R M
Vliegen, Hubert W
Treskes, Roderick W
Schalij, Martin J
Atsma, Douwe E
Egorova, Anastasia D
author_facet Nederend, Marieke
Zandstra, Tjitske E
Kiès, Philippine
Jongbloed, Monique R M
Vliegen, Hubert W
Treskes, Roderick W
Schalij, Martin J
Atsma, Douwe E
Egorova, Anastasia D
author_sort Nederend, Marieke
collection PubMed
description AIMS: Patients with a systemic right ventricle (sRV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA are prone to heart failure and arrhythmias. This study evaluated feasibility, patient adherence, and satisfaction of a smart technology-based care pathway for heart failure treatment optimization in these patients. METHODS AND RESULTS: Patients with symptomatic sRV failure eligible for initiation of sacubitril/valsartan were provided with four smartphone compatible devices (blood pressure monitor, weight scale, step counter, and rhythm monitor) and were managed according to a smart technology-based care pathway. Biweekly sacubitril/valsartan titration visits were replaced by electronical visits, patients were advised to continue measurements at least weekly after titration. Data of 24 consecutive sRV patients (median age 47 years, 50% female) who participated in the smart technology-based care pathway were analysed. Median home-hospital distance was 65 km (maximum 227 km). Most patients (20, 83.3%) submitted weekly measurements; 100% submitted prior to electronical visits. Titration conventionally occurs during a hospital visit. By implementing eHealth smart technology, 68 such trips to hospital were replaced by virtual visits facilitated by remote monitoring. An eHealth questionnaire was completed by 22 patients (92%), and 96% expressed satisfaction. After titration, 30 instances of remote adjustment of heart failure medication in addition to scheduled outpatient clinic visits occurred, one (4%) heart failure admission followed, despite ambulant adjustments. Five patients (21%) sent in rhythm registrations (n = 17), of these 77% showed sinus rhythm, whereas supraventricular tachycardia was detected in the remaining four registrations. CONCLUSION: These data suggest that implementation of a smart technology-based care pathway for optimization of medical treatment sRV failure is feasible with high measurement adherence and patient satisfaction.
format Online
Article
Text
id pubmed-9707956
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97079562023-01-27 Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure Nederend, Marieke Zandstra, Tjitske E Kiès, Philippine Jongbloed, Monique R M Vliegen, Hubert W Treskes, Roderick W Schalij, Martin J Atsma, Douwe E Egorova, Anastasia D Eur Heart J Digit Health Original Articles AIMS: Patients with a systemic right ventricle (sRV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA are prone to heart failure and arrhythmias. This study evaluated feasibility, patient adherence, and satisfaction of a smart technology-based care pathway for heart failure treatment optimization in these patients. METHODS AND RESULTS: Patients with symptomatic sRV failure eligible for initiation of sacubitril/valsartan were provided with four smartphone compatible devices (blood pressure monitor, weight scale, step counter, and rhythm monitor) and were managed according to a smart technology-based care pathway. Biweekly sacubitril/valsartan titration visits were replaced by electronical visits, patients were advised to continue measurements at least weekly after titration. Data of 24 consecutive sRV patients (median age 47 years, 50% female) who participated in the smart technology-based care pathway were analysed. Median home-hospital distance was 65 km (maximum 227 km). Most patients (20, 83.3%) submitted weekly measurements; 100% submitted prior to electronical visits. Titration conventionally occurs during a hospital visit. By implementing eHealth smart technology, 68 such trips to hospital were replaced by virtual visits facilitated by remote monitoring. An eHealth questionnaire was completed by 22 patients (92%), and 96% expressed satisfaction. After titration, 30 instances of remote adjustment of heart failure medication in addition to scheduled outpatient clinic visits occurred, one (4%) heart failure admission followed, despite ambulant adjustments. Five patients (21%) sent in rhythm registrations (n = 17), of these 77% showed sinus rhythm, whereas supraventricular tachycardia was detected in the remaining four registrations. CONCLUSION: These data suggest that implementation of a smart technology-based care pathway for optimization of medical treatment sRV failure is feasible with high measurement adherence and patient satisfaction. Oxford University Press 2021-02-22 /pmc/articles/PMC9707956/ /pubmed/36712397 http://dx.doi.org/10.1093/ehjdh/ztab028 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Nederend, Marieke
Zandstra, Tjitske E
Kiès, Philippine
Jongbloed, Monique R M
Vliegen, Hubert W
Treskes, Roderick W
Schalij, Martin J
Atsma, Douwe E
Egorova, Anastasia D
Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
title Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
title_full Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
title_fullStr Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
title_full_unstemmed Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
title_short Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
title_sort potential of ehealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707956/
https://www.ncbi.nlm.nih.gov/pubmed/36712397
http://dx.doi.org/10.1093/ehjdh/ztab028
work_keys_str_mv AT nederendmarieke potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT zandstratjitskee potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT kiesphilippine potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT jongbloedmoniquerm potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT vliegenhubertw potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT treskesroderickw potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT schalijmartinj potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT atsmadouwee potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure
AT egorovaanastasiad potentialofehealthsmarttechnologyinoptimizationandmonitoringofheartfailuretreatmentinadultswithsystemicrightventricularfailure